Business
Celyad Oncology Reports First Half Year 2025 Financial Results
MONT-SAINT-GUIBERT, Belgium, September 25, 2025--Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company"), today announced its financial results for the first half year 2025 ended June 30, 2025.
About this update from Celyad Oncology Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/6b51b2ab9981ee77d5cab324edf5b6b5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.1QFb4E6SEt.SOxUfWp1vg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6b51b2ab9981ee77d5cab324edf5b6b5","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4CnB0VsbAMvwUwUenQ4OBA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/6b51b2ab9981ee77d5cab324edf5b6b5","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MONT-SAINT-GUIBERT, Belgium, September 25, 2025--(BUSINESS WIRE)--Regulatory News:","length":82,"tagName":"p"},{"type":"text","content":"Celyad Oncology (Euronext: CYAD) (the "Company"), today announced its financial results for the first half year 2025 ended June 30, 2025.","length":147,"tagName":"p"},{"type":"text","content":"First Half 2025 financial review","length":32,"tagName":"p"},{"type":"text","content":"As of June 30, 2025, the Company’s Treasury position amounted to €0.8 million.","length":78,"tagName":"p"},{"type":"text","content":"After due consideration of detailed budgets and estimated cash flow forecasts for the years 2025 and 2026, the Company projects that its existing cash and cash equivalents will be sufficient to fund its estimated operating and capital expenditures into the fourth quarter of 2025.","length":280,"tagName":"p"},{"type":"text","content":"Key financial figures for first half 2025, compared with the first half of 2024 and full year 2024, are summarized below:","length":121,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;background-color:#CCEEFF;width:55%;padding-left:5.0px;","val":[{"type":"text","content":"Selected key financial figures (€ millions)","length":43,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;background-color:#CCEEFF;width:15%;text-align:center;list-style-position:inside;padding...